earnings

Cardinal Health logs fiscal Q1 sales miss, earnings beat, announces CEO succession
Cardinal Health logs fiscal Q1 sales miss, earnings beat, announces CEO succession
Mass Device
Cardinal Health
earnings
devices
Flag link:
Mylan: Bad Earnings, Good News?
Mylan: Bad Earnings, Good News?
Barron's
Mylan Labs
earnings
Copaxone
Teva Pharmaceutical
Flag link:
Earnings Preview: What To Expect From Valeant Pharmaceuticals On Tuesday
Earnings Preview: What To Expect From Valeant Pharmaceuticals On Tuesday
Forbes
earnings
Valeant Pharmaceuticals
Flag link:
Momenta's (MNTA) Biosimilar Study Fails, Q3 Loss Narrows
Momenta's (MNTA) Biosimilar Study Fails, Q3 Loss Narrows
Yahoo/Zacks.com
Momenta
earnings
biosimilars
M834
Orencia
Flag link:
Teva Earnings Miss by Record Margin
Teva Earnings Miss by Record Margin
Bloomberg
Teva Pharmaceutical
earnings
Flag link:
Insys takes $150M charge in Q3 as it works to settle Subsys probe
Insys takes $150M charge in Q3 as it works to settle Subsys probe
Fierce Pharma
INSYS Therapeutics
earnings
Subsys
Flag link:
Juno Therapeutics' 3rd Quarter Boosted by Potential Rival Novartis
Juno Therapeutics' 3rd Quarter Boosted by Potential Rival Novartis
Yahoo/Motley Fool
Juno Therapeutics
earnings
Novartis
Flag link:
Becton, Dickinson beats The Street with Q4, 2017 numbers
Becton, Dickinson beats The Street with Q4, 2017 numbers
Mass Device
Becton Dickinson
earnings
devices
Flag link:
How Allergan plc Lost $4 Billion in Q3 and Still Performed Quite Well
How Allergan plc Lost $4 Billion in Q3 and Still Performed Quite Well
Motley Fool
Allergan
earnings
Flag link:
Novo Nordisk shares slip on cautious guidance, insulin pricing concerns
Novo Nordisk shares slip on cautious guidance, insulin pricing concerns
Drug Delivery Business News
Novo Nordisk
earnings
diabetes
insulin
drug pricing
Flag link:
Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt
Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt
Marketwatch
Teva Pharmaceutical
earnings
Flag link:
Pfizer beats 3Q net forecasts on lower charges, higher sales
Pfizer beats 3Q net forecasts on lower charges, higher sales
Yahoo/AP
Pfizer
earnings
Flag link:
What to expect from the rest of pharma's earnings
What to expect from the rest of pharma's earnings
BioPharma Dive
earnings
Pfizer
Allergan
Novo Nordisk
Sanofi
AstraZeneca
Flag link:
3 Bright Spots in Merck's Q3 Results
3 Bright Spots in Merck's Q3 Results
Motley Fool
Merck
earnings
Keytruda
Zepatier
animal health
Flag link:
Merck's cyber-attack shaved $135 million off sales
Merck's cyber-attack shaved $135 million off sales
Marketwatch
Merck
cyberattack
cybersecurity
earnings
Flag link:
Mydayis sales shine as Shire still looks to divest neuro
Mydayis sales shine as Shire still looks to divest neuro
BioPharma Dive
Shire
Mydayis
earnings
Flag link:
Earnings Preview: What To Expect From Pfizer On Tuesday
Earnings Preview: What To Expect From Pfizer On Tuesday
Forbes
earnings
Pfizer
Flag link:
Vertex Pharmaceuticals Incorporated: One Eye on Earnings, One on the Pipeline
Vertex Pharmaceuticals Incorporated: One Eye on Earnings, One on the Pipeline
Motley Fool
earnings
Vertex Pharmaceuticals
Flag link:
Under breakup pressure, Shire cheers grumpy investors with Q3 earnings beat
Under breakup pressure, Shire cheers grumpy investors with Q3 earnings beat
Fierce Pharma
Shire
earnings
Flag link:
There's a Lot to Like in AbbVie's Q3 Update
There's a Lot to Like in AbbVie's Q3 Update
Motley Fool
AbbVie
earnings
Humira
Imbruvica
Mavyret
Flag link:

Pages